The Longevity Revolution Is Here | Lifespan with Dr. David Sinclair - S2, Ep. 1

The Lifespan Podcast

The Longevity Revolution Is Here | Lifespan with Dr. David Sinclair - S2, Ep. 1

30 mins

In this episode of Lifespan, Dr. David Sinclair challenges the idea that aging is inevitable. Aging is a treatable root cause of the world's most serious diseases, and the science to address it is finally here. Drawing on thirty years of research, Dr. Sinclair introduces the Information Theory of Aging (ITOA), the idea that aging is a loss of biological information and cellular identity.

By looking at what is already possible at the limits of human longevity, physical performance, and cognitive function, Dr. Sinclair reveals the extraordinary biological potential sitting inside each of us. He also cuts through conflicting wellness claims to explain why AI and gene therapies are driving a revolution in longevity medicine. In January 2026, ER-100 became the world's first epigenetic reprogramming therapy to receive FDA clearance for human trials. It is designed to reset the biological age of damaged nerve cells and restore lost vision. The era of treating aging at its root has officially begun.

×

Watch

The Science of Living Longer

Inspired by David Sinclair’s Lifespan: Why We
Age—and Why We Don’t Have To

Episode Overview

In this episode, we explore the groundbreaking ideas from Lifespan, where biologist David Sinclair argues that aging is a disease — and one that can be treated. We’ll discuss the science of longevity, how lifestyle choices impact our biological age, and what it means to live healthier, longer lives.

“Aging is a disease, and that disease is treatable.” — David Sinclair

Introduction

  • Host greets listeners and introduces the episode’s theme: “Can we slow, or even reverse, the process of aging?”
  • Brief context on David Sinclair and his work at Harvard.
  • Personal reflection or hook: how the idea of “reversing age” challenges everything we think we know about life.

00:00

David Sinclair

Lorem ipsum dolor sit amet consectetur. Tincidunt fermentum in at risus vestibulum vestibulum purus donec dignissim. Eget nullam elementum in elementum in congue. Pellentesque elementum pharetra diam arcu varius. Justo vel et facilisis nisl in a ac. Lectus tincidunt lorem nibh ultricies mattis urna netus consectetur.

00:15

John Doe

Lorem ipsum dolor sit amet consectetur. Tincidunt fermentum in at risus vestibulum vestibulum purus donec dignissim.

00:24

David Sinclair

Lorem ipsum dolor sit amet consectetur. Tincidunt fermentum in at risus vestibulum vestibulum purus donec dignissim. Eget nullam elementum in elementum in congue. Pellentesque elementum pharetra diam arcu varius. Justo vel et facilisis nisl in a ac. Lectus tincidunt lorem nibh ultricies mattis urna netus consectetur.

01:15

John Doe

Lorem ipsum dolor sit amet consectetur. Tincidunt fermentum in at risus vestibulum vestibulum purus donec dignissim.

The Science of Living Longer Inspired by David Sinclair’s Lifespan: Why We Age—and Why We Don’t Have To Episode Overview In this episode, we explore the groundbreaking ideas from Lifespan, where biologist David Sinclair argues that aging is a disease — and one that can be treated. We’ll discuss the science of longevity, how lifestyle choices impact our biological age, and what it means to live healthier, longer lives. “Aging is a disease, and that disease is treatable.” — David Sinclair Introduction Host greets listeners and introduces the episode’s theme: “Can we slow, or even reverse, the process of aging?” Brief context on David Sinclair and his work at Harvard. Personal reflection or hook: how the idea of “reversing age” challenges everything we think we know about life.

Go Beyond Listening
Get More as a Member

Extended show notes — Access extended notes with references, highlights, and key takeaways.

Ask Me Anything with David Sinclair — Submit your questions and hear them answered in exclusive episodes.

Early Access + Bonus Content — Get early access to upcoming episodes and unreleased discussions.


Proceeds are going to support medical research.